Repligen Corp

Company Profile

• Business description

  Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

• Contact

  41 Seyon Street
  Building 1, Suite 100
  WalthamMA02453
  USA

  T: +1 781 250-0111

  E: investors@repligen.com

  https://www.repligen.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Instruments & Supplies

  Fiscal Year End

  31 December 2025

  Employees

  1,778